Insider Transactions in Q2 2024 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
1,500
-27.27%
|
$46,500
$31.3 P/Share
|
|
Jun 03
2024
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
1,000
-7.91%
|
$29,000
$29.08 P/Share
|
|
May 16
2024
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,748
-0.62%
|
$953,188
$31.04 P/Share
|
|
May 16
2024
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,667
+1.22%
|
-
|
|
May 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,943
-15.42%
|
$432,233
$31.04 P/Share
|
|
May 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,507
+23.33%
|
-
|